[ad_1]
Ali Mokdad, PhD, chief strategy officer for population health, University of Washington, Seattle.
Eric Topol, MD, executive vice president, Scripps Research; founder and director, Scripps Research Translational Institute, La Jolla, CA; editor-in-chief, Medscape.
Justin Lessler, PhD, professor of epidemiology, University of North Carolina, Chapel Hill.
Amesh Adalja, MD, senior scholar, Johns Hopkins Center for Health Security, Baltimore.
Twitter: @ASlavitt, July 26, 2021.
Nature: “Variant-proof vaccines — invest now for the next pandemic.”
American Society for Microbiology: “How Dangerous Is the Delta Variant (B.1.617.2)?”
Johns Hopkins University: COVID-19 Data Repository, COVID tracker.
CDC: “COVID Data Tracker.”
CNN: “More infectious Delta variant makes up 83% of new coronavirus cases as vaccine hesitancy persists.”
National Geographic: “The Unusual Lambda variant is rapidly spreading in South America.”
WebMD, Medscape: “Delta Variant Could Drive Herd Immunity Threshold Over 80%.”
The Korea Herald: “Korea confirms first two cases of delta plus.”
NPR: “The Delta Variant Will Drive A Steep Rise in U.S. COVID Deaths, A New Model Shows.”
COVID-19 Scenario Modeling Hub.
